Novozymes A/S

Novozymes A/S

NVZMY

$67.61

Updated: 23/09/2026, 07:10:55

Market Cap
$31.52B
Sector
Basic Materials
Industry
Chemicals - Specialty
Country
DK
Stock valuation chart
One-year closing share-price history for NVZMY
Company Profile

Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific region. The company's broad range of products caters to numerous sectors: Food and Beverages: Supplying ingredients and processing aids for baking, a variety of beverages, dairy production, starch modification, and protein applications. Household Care: Delivering specialized formulations for laundry, dishwashing, and professional cleaning solutions. Agriculture: Providing innovations for crop cultivation, animal health and nutrition, alongside bioyield and biocontrol products for plant growth. Bioenergy and Industrial Processing: Offering critical components for grain and technical processing, encompassing liquefaction, saccharification, fermentation, fiber conversion, and biomass transformation. Textiles: Featuring technologies for biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing. Pulp and Paper: Enhancing processes through fiber modification, bleach boosting, deposit control, starch modification, and deinking agents. Leather Production: Furnishing treatments for acid bating, area expansion, general bating, degreasing, soaking, and unhairing/liming stages. Water and Waste Management: Contributing with bioaugmentation strategies, optimization of biogas production, and sludge management. Pharmaceuticals: Supplying specialized lipases (both free and immobilized), proteases for biocatalysis, and rTrypsin vital for cell culture applications. Furthermore, Novozymes provides offerings related to human health and various protein-based products. Founded in 1925, Novozymes A/S is headquartered in Bagsvaerd, Denmark.

USD
OTC
CEO: Ester Baiget
Employees: 11,641
https://www.novonesis.com
Asset Summaries
Latest generated summaries for NVZMY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for NVZMY.
Share price
$67.61
Market cap
$31.52B
Exchange
OTC
Currency
USD
CEO
Ester Baiget
Employees
11,641
IPO date
20/01/2010
Beta
0.623
Last dividend
$0.00
Day range
$67.13 – $67.91
52-week range
$49.90 – $75.27
1-day performance
2.42%
1-year performance
35.49%
Current drawdown (1Y)
-10.18%
CIK
0001131345
CUSIP
670108109
ISIN
US6701081092
Created
07/12/2025, 05:32:31
Last update
23/09/2026, 07:10:55

Track Novozymes A/S with an AI analyst

See which prediction-market events move NVZMY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.